TrianglePUBLICATIONS · 26644412
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2016 Apr 15
- First author
- Tarlock K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Tarlock K
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Sung L
- type
- Author
- name
- Pollard JA
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Loken MR
- type
- Author
- name
- Gamis AS
- type
- Author
- name
- Meshinchi S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Tarlock K
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Raimondi SC
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Sung L
- type
- Author
- name
- Pollard JA
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Loken MR
- type
- Author
- name
- Gamis AS
- type
- Author
- name
- Meshinchi S
- type
- Author
- bibliography ids
- nci-bib-6d1c54cad050d741874d9436
- book metadata
- content sha256
- f5e6e9d7ed2bc807d4ba67505d72eed6914b01d9a01ea36108dec534d0be7e92
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-15-1349
- electronic publication date
- display
- 2015 Dec 7
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26644412
- immutable id
- pubmed:26644412@f5e6e9d7ed2bc807d4ba67505d72eed6914b01d9a01ea36108dec534d0be7e92
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 8
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 1951-7
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26644412
- provenance
- batch id
- 948d34b0dea86780a31d
- provider
- NCBI PubMed ESummary
- record sha256
- 11d7c7795384765162a52135b447693c0f8cfd12a4a92158f6208032a9d80842
- response sha256
- 11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
- retrieved at
- 2026-09-09T23:47:15.495091+00:00
- publication date
- display
- 2016 Apr 15
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Preserved source evidence · Not medical advice